Getagraph.com logo
S&P 500
(0.30%) 5 115.39 points
Dow Jones
(0.30%) 38 354 points
Nasdaq
(0.35%) 15 984 points
Oil
(-0.95%) $83.05
Gas
(5.36%) $2.03
Gold
(0.31%) $2 354.40
Silver
(0.56%) $27.69
Platinum
(4.31%) $961.85
USD/EUR
(-0.27%) $0.932
USD/NOK
(-0.44%) $10.98
USD/GBP
(-0.58%) $0.796
USD/RUB
(1.63%) $93.37

リアルタイムの更新： Codexis Inc [CDXS]

取引所: NASDAQ セクター: Healthcare 産業: Biotechnology
Upcoming Earnings Alert

3 days till quarter result
(amc 2024-05-02)

Expected move: +/- 6.91%

BUY
100.00%
return 6.40%
SELL
75.00%
return 1.73%
最終更新日時30 4月 2024 @ 01:50
25% discount on Stockinvest.us - Use code: Podcast

13.91% $ 3.03

売る 108140 min ago

@ $2.88

発行日: 14 2月 2024 @ 23:31

リターン: 5.24%

前回のシグナル: 2月 13 - 23:30

前回のシグナル: 買う

リターン: 0.67 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:50):
Profile picture for Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening...

Stats
本日の出来高 195 028
平均出来高 574 614
時価総額 213.02M
EPS $0 ( 2024-02-28 )
次の収益日 ( $-0.170 ) 2024-05-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.71
ATR14 $0.00600 (0.20%)
Insider Trading
Date Person Action Amount type
2024-01-01 Ryali Sriram Buy 314 125 Stock Option (Right to Buy)
2024-01-01 Ryali Sriram Buy 52 350 Common Stock
2024-01-01 Norrett Kevin Buy 314 125 Stock Option (Right to Buy)
2024-01-01 Norrett Kevin Buy 52 350 Common Stock
2024-01-01 Fitzgerald Margaret Nell Buy 314 125 Stock Option (Right to Buy)
INSIDER POWER
79.09
Last 93 transactions
Buy: 6 649 590 | Sell: 1 047 461

ボリューム 相関

長: 0.13 (neutral)
短: 0.78 (moderate)
Signal:(36.559) Neutral

Codexis Inc 相関

10 最も正の相関
ZD0.978
SRTS0.967
LGHL0.958
NWL0.954
NMTR0.952
TBNK0.952
GDS0.95
MODV0.949
WMG0.949
TRIP0.948
10 最も負の相関
MTRY-0.947
AHRN-0.943
AFAR-0.94
FRSG-0.939
MCAA-0.938
TBSA-0.934
LEGA-0.933
CITE-0.932
NBSTU-0.931
MSDA-0.931

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Codexis Inc 相関 - 通貨/商品

The country flag 0.61
( weak )
The country flag -0.02
( neutral )
The country flag 0.00
( neutral )
The country flag 0.29
( neutral )
The country flag 0.22
( neutral )
The country flag 0.02
( neutral )

Codexis Inc 財務諸表

Annual 2023
収益: $70.14M
総利益: $51.82M (73.87 %)
EPS: $-1.120
FY 2023
収益: $70.14M
総利益: $51.82M (73.87 %)
EPS: $-1.120
FY 2022
収益: $138.59M
総利益: $100.56M (72.56 %)
EPS: $-0.510
FY 2021
収益: $104.75M
総利益: $82.55M (78.80 %)
EPS: $-0.330

Financial Reports:

No articles found.

Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。